| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |